Current and Novel Therapies for Cluster Headache: A Narrative Review
Abstract Cluster headache (CH) is an excruciating and debilitating primary headache disorder. The prevalence is up to 1.3%, and the typical onset is around age 30. Often misdiagnosed as migraine, particularly in children, the diagnosis rate of CH has been increasing among women. CH is characterized...
Saved in:
| Main Authors: | Bruna de Freitas Dias, Christopher L. Robinson, Maria Dolores Villar-Martinez, Sait Ashina, Peter J. Goadsby |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-11-01
|
| Series: | Pain and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40122-024-00674-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of artificial intelligence performance in answering questions on onabotulinum toxin and sacral neuromodulation
by: Ibrahim Hacibey, et al.
Published: (2025-05-01) -
Pretreatment with an anti-CGRP monoclonal antibody attenuates mild TBI-induced tactile hypersensitivity in mice
by: Anne-Sophie Wattiez, et al.
Published: (2025-08-01) -
Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update
by: Pedro Augusto Sampaio Rocha-Filho, et al.
Published: (2025-06-01) -
Induction of more severe central sensitization in a medication overuse headache model mice through active ingestion of rizatriptan
by: Zhenjie Ma, et al.
Published: (2025-05-01) -
Efficacy and safety of anti-CGRP(r) monoclonal antibodies in real clinical practice: preliminary analysis after three months of therapy
by: N. V. Vashchenko, et al.
Published: (2021-12-01)